InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Passage BIO, Inc.

PASG Clue Score25
United States Fiscal year ends December CIK 0001787297 Results filed 3 Mar 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

42
Insider
Date
Role
Action
Shares
Price
Amount
Lynx1 Capital Management LP
25 Jun 2026
10% owner
Buy indirect
50,055
$4.12
$206.10K
Lynx1 Capital Management LP
15 Sep 2025
10% owner
Buy indirect
11,900
$6.99
$83.18K
Lynx1 Capital Management LP
12 Sep 2025
10% owner
Buy indirect
19,783
$6.99
$138.30K
Lynx1 Capital Management LP
11 Sep 2025
10% owner
Buy indirect
325
$6.96
$2.26K
Lynx1 Capital Management LP
24 Jul 2025
10% owner
Buy indirect
66,423
$5.71
$379.45K
Lynx1 Capital Management LP
23 Jul 2025
10% owner
Buy indirect
49,302
$5.74
$283.03K
Lynx1 Capital Management LP
22 Jul 2025
10% owner
Buy indirect
13,123
$5.44
$71.34K
Lynx1 Capital Management LP
27 Dec 2024
10% owner
Buy indirect
373,645
$0.65
$241.04K
Lynx1 Capital Management LP
27 Nov 2024
10% owner
Buy indirect
29,300
$0.67
$19.66K
Lynx1 Capital Management LP
26 Nov 2024
10% owner
Buy indirect
167,055
$0.71
$118.19K
Lynx1 Capital Management LP
25 Nov 2024
10% owner
Buy indirect
259,998
$0.56
$146.66K
Orbimed Advisors LLC
28 Jun 2023
10% owner
Buy indirect
575,195
$0.84
$483.16K
Orbimed Advisors LLC
27 Jun 2023
10% owner
Buy indirect
617,382
$0.84
$518.60K
Orbimed Advisors LLC
4 May 2022
10% owner
Buy indirect
303,500
$1.94
$588.79K
Orbimed Advisors LLC
3 May 2022
10% owner
Buy indirect
221,500
$1.93
$427.50K
Bruce A Goldsmith
21 Mar 2022
CEO and President
Buy
10,000
$3.15
$31.50K
Orbimed Advisors LLC
20 Jan 2022
10% owner
Buy indirect
369,100
$5.42
$2.00M
Orbimed Advisors LLC
19 Jan 2022
10% owner
Buy indirect
43,300
$5.11
$221.26K
Orbimed Advisors LLC
18 Jan 2022
10% owner
Buy indirect
114,700
$5.46
$626.26K
Orbimed Advisors LLC
14 Jan 2022
10% owner
Buy indirect
10,300
$5.60
$57.68K
Orbimed Advisors LLC
13 Jan 2022
10% owner
Buy indirect
41,800
$5.52
$230.74K
Orbimed Advisors LLC
12 Jan 2022
10% owner
Buy indirect
100,000
$5.65
$565.00K
Orbimed Advisors LLC
11 Jan 2022
10% owner
Buy indirect
8,200
$5.53
$45.35K
Bruce A Goldsmith
21 May 2021
CEO and President
Buy
2,000
$13.12
$26.23K
Richard Steven Morris
21 May 2021
Chief Financial Officer
Buy
2,171
$13.82
$30.00K
Athena Countouriotis
24 Mar 2020
Director
Buy
10,000
$14.98
$149.75K
Edgar B. Cale
3 Mar 2020
GC and Corporate Secretary
Buy
2,000
$18.00
$36.00K
Athena Countouriotis
3 Mar 2020
Director
Buy
8,900
$18.00
$160.20K
Alexandros Fotopoulos
3 Mar 2020
Chief Technical Officer
Buy
5,500
$18.00
$99.00K
Bruce A Goldsmith
3 Mar 2020
CEO and President
Buy
1,100
$18.00
$19.80K
Saqib Islam
3 Mar 2020
Director
Buy
5,000
$18.00
$90.00K
Sandip Kapadia
3 Mar 2020
Director
Buy
5,000
$18.00
$90.00K
Richard Steven Morris
3 Mar 2020
Chief Financial Officer
Buy
400
$18.00
$7.20K
Jill M. Quigley
3 Mar 2020
Chief Operating Officer
Buy indirect
1,000
$18.00
$18.00K
Jill M. Quigley
3 Mar 2020
Chief Operating Officer
Buy
1,500
$18.00
$27.00K
Liam Ratcliffe
3 Mar 2020
Director
Buy
2,800
$18.00
$50.40K
Tadataka Yamada
3 Mar 2020
Director
Buy
6,500
$18.00
$117.00K
Patrick J Heron
3 Mar 2020
Director
Buy indirect
550,000
$18.00
$9.90M
Thomas Woiwode
3 Mar 2020
Director
Buy indirect
225,000
$18.00
$4.05M
Frazier Life Sciences IX, L.P.
3 Mar 2020
10% owner
Buy
550,000
$18.00
$9.90M
Versant Venture Capital VI, L.P.
3 Mar 2020
10% owner
Buy indirect
225,000
$18.00
$4.05M
Orbimed Advisors LLC
28 Feb 2020
10% owner
Buy indirect
373,300
$18.00
$6.72M
Show all 86 transactions →

What was left out

Form 4 filings counted 163
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 23
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 36
Transactions with no price 0
Shares from compensation/vesting 24,273,474
Sales filed before the plan box existed 4
History held since 2 Mar 2020